To better understand how to construct a mucosal vaccine that could protect the tissues that are the earlier targets of HIV infection, we focused on CCL28, a chemokine that plays an important role in the migration of IgA-ASC in the mucosal lamina propria [7]. This evidence concerns the gene CCL28 and HIV infectious disease.